Edwards Lifesciences Corp Quarterly Goodwill in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Edwards Lifesciences Corp quarterly Goodwill history and growth rate from Q2 2010 to Q4 2024.
  • Edwards Lifesciences Corp Goodwill for the quarter ending December 31, 2024 was $1.78B, a 55.2% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.78B +$632M +55.2% Dec 31, 2024 10-K 2025-02-28
Q3 2024 $1.61B +$308M +23.7% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $1.15B -$149M -11.4% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.25B -$55.6M -4.25% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $1.15B +$80.3M +7.54% Dec 31, 2023 10-K 2025-02-28
Q3 2023 $1.3B +$139M +12% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $1.3B +$135M +11.6% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $1.31B +$142M +12.2% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $1.06B -$103M -8.83% Dec 31, 2022 10-K 2025-02-28
Q3 2022 $1.16B -$11.7M -1% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $1.16B -$7.7M -0.66% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $1.17B -$4.5M -0.38% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $1.17B -$5.3M -0.45% Dec 31, 2021 10-K 2024-02-12
Q3 2021 $1.17B +$400K +0.03% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $1.17B +$4.1M +0.35% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $1.17B +$4.6M +0.39% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $1.17B +$5.5M +0.47% Dec 31, 2020 10-K 2023-02-13
Q3 2020 $1.17B +$13.4M +1.16% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 $1.17B -$6.2M -0.53% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $1.17B +$62.8M +5.69% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $1.17B +$55.5M +4.99% Dec 31, 2019 10-K 2022-02-14
Q3 2019 $1.16B +$34.3M +3.06% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $1.17B +$55.3M +4.94% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $1.1B -$41.4M -3.62% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 $1.11B -$14.3M -1.27% Dec 31, 2018 10-K 2021-02-12
Q3 2018 $1.12B +$142M +14.5% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $1.12B +$154M +15.9% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $1.14B +$200M +21.1% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $1.13B +$500M +79.9% Dec 31, 2017 10-K 2020-02-14
Q3 2017 $981M +$351M +55.6% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $965M +$336M +53.3% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $945M +$314M +49.8% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $626M -$2.2M -0.35% Dec 31, 2016 10-K 2019-02-15
Q3 2016 $630M +$8.8M +1.42% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $629M +$259M +69.7% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $631M +$263M +71.3% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $628M +$252M +67.1% Dec 31, 2015 10-K 2018-02-16
Q3 2015 $621M +$242M +63.9% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $371M -$13.4M -3.49% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $368M -$17M -4.41% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $376M -$9.4M -2.44% Dec 31, 2014 10-K 2017-02-17
Q3 2014 $379M -$4.8M -1.25% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $384M +$2.8M +0.73% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $385M +$5.2M +1.37% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $385M +$700K +0.18% Dec 31, 2013 10-K 2016-02-19
Q3 2013 $384M +$34M +9.72% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $382M +$31.7M +9.06% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $380M +$30.4M +8.69% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $385M +$34.9M +9.98% Dec 31, 2012 10-K 2015-02-20
Q3 2012 $350M $0 0% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $350M -$100K -0.03% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $350M -$100K -0.03% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $350M +$34.6M +11% Dec 31, 2011 10-K 2014-02-28
Q3 2011 $350M +$34.6M +11% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $350M +$34.7M +11% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $350M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $315M Dec 31, 2010 10-K 2013-02-28
Q3 2010 $315M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $315M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.